Review
Accepted on 16 Jun 2025
Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: realworld adverse event analysis based on the FDA adverse event reporting system (FAERS)
in Predictive Toxicology
Review
Accepted on 16 Jun 2025
in Predictive Toxicology
Review
Accepted on 16 Jun 2025
in Terrestrial Microbiology
Review
Accepted on 16 Jun 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 16 Jun 2025
in Health Psychology
Brief Research Report
Accepted on 16 Jun 2025
in Cardiac Electrophysiology
Original Research
Accepted on 16 Jun 2025
in Epigenomics and Epigenetics
Original Research
Accepted on 16 Jun 2025
in Inflammation Pharmacology
Original Research
Accepted on 16 Jun 2025
in Gynecological Oncology
Review
Accepted on 16 Jun 2025
in Inflammation
Original Research
Accepted on 16 Jun 2025
in Geriatric Medicine
Case Report
Accepted on 16 Jun 2025
in Veterinary Neurology and Neurosurgery
Review
Accepted on 16 Jun 2025
in Inflammation
Original Research
Accepted on 16 Jun 2025
in Veterinary Regenerative Medicine
Original Research
Accepted on 16 Jun 2025
in Clinical Diabetes
Brief Research Report
Accepted on 16 Jun 2025
in Veterinary Epidemiology and Economics
Original Research
Accepted on 16 Jun 2025
in Veterinary Clinical, Anatomical, and Comparative Pathology